Cumberland Pharmaceuticals announced the appointment of biopharmaceutical industry veteran Adam Haeberle, Ph.D. as senior director, clinical and regulatory affairs. His responsibilities will include overseeing company's product development team in support of its efforts to design and implement clinical studies. Dr. Haeberle joins company from Amgen Inc. where he held a series of director-level clinical development roles, including development clinical director.